PASCOE KEVIN CARLTON 4
Accession 0001127602-24-023016
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 5:15 PM ET
Size
40.5 KB
Accession
0001127602-24-023016
Insider Transaction Report
- Exercise/Conversion
Common Stock
2024-08-23$69.20/sh+18,334$1,268,713→ 94,893 total - Exercise/Conversion
Stock Options (Right to Buy) 2-25-2021
2024-08-23−18,333→ 0 totalExercise: $69.20From: 2021-02-25Exp: 2026-02-25→ Common Stock (18,333 underlying) - Exercise/Conversion
Common Stock
2024-08-23$54.73/sh+8,500$465,205→ 111,893 total - Exercise/Conversion
Common Stock
2024-08-23$57.76/sh+8,500$490,960→ 157,060 total - Exercise/Conversion
Common Stock
2024-08-23$69.20/sh+18,333$1,268,644→ 76,559 total - Exercise/Conversion
Common Stock
2024-08-23$53.41/sh+18,333$979,166→ 130,226 total - Exercise/Conversion
Stock Options (Right to Buy) 2-25-2021
2024-08-23−18,333→ 0 totalExercise: $69.20From: 2022-02-25Exp: 2026-02-25→ Common Stock (18,333 underlying) - Tax Payment
Common Stock
2024-08-23$78.63/sh−101,230$7,959,715→ 55,830 total - Exercise/Conversion
Stock Options (Right to Buy) 2-25-2021
2024-08-23−18,334→ 0 totalExercise: $69.20From: 2023-02-25Exp: 2026-02-25→ Common Stock (18,334 underlying) - Exercise/Conversion
Stock Option (Right to buy) 2022
2024-08-23−18,334→ 0 totalExercise: $53.41From: 2024-02-25Exp: 2027-02-25→ Common Stock (18,334 underlying) - Exercise/Conversion
Common Stock
2024-08-23$69.20/sh+18,333$1,268,644→ 58,226 total - Exercise/Conversion
Common Stock
2024-08-23$54.73/sh+8,500$465,205→ 103,393 total - Exercise/Conversion
Stock Option (Right to Buy) 2023
2024-08-23−8,500→ 0 totalExercise: $54.73From: 2023-02-24Exp: 2028-02-24→ Common Stock (8,500 underlying) - Exercise/Conversion
Stock Option (Right to Buy) 2024
2024-08-23−8,500→ 0 totalExercise: $57.76From: 2024-02-23Exp: 2029-02-23→ Common Stock (8,500 underlying) - Exercise/Conversion
Common Stock
2024-08-23$53.41/sh+18,334$979,219→ 148,560 total - Exercise/Conversion
Stock Option (Right to buy) 2022
2024-08-23−18,333→ 0 totalExercise: $53.41From: 2023-02-25Exp: 2027-02-25→ Common Stock (18,333 underlying) - Exercise/Conversion
Stock Option (Right to Buy) 2023
2024-08-23−8,500→ 0 totalExercise: $54.73From: 2024-02-24Exp: 2028-02-24→ Common Stock (8,500 underlying)
- 18,333
Stock Options (Right to Buy) 2-21-2020
Exercise: $90.79From: 2021-02-21Exp: 2025-02-21→ Common Stock (18,333 underlying) - 8,500
Stock Option (Right to Buy) 2024
Exercise: $57.76From: 2025-02-23Exp: 2029-02-23→ Common Stock (8,500 underlying) - 18,334
Stock Options (Right to Buy) 2-21-2020
Exercise: $90.79From: 2022-02-21Exp: 2025-02-21→ Common Stock (18,334 underlying) - 18,333
Stock Options (Right to Buy) 2-21-2020
Exercise: $90.79From: 2020-02-21Exp: 2025-02-21→ Common Stock (18,333 underlying) - 8,500
Stock Option (Right to Buy) 2024
Exercise: $57.76From: 2026-02-23Exp: 2029-02-23→ Common Stock (8,500 underlying) - 8,500
Stock Option (Right to Buy) 2023
Exercise: $54.73From: 2025-02-24Exp: 2028-02-24→ Common Stock (8,500 underlying)
Footnotes (1)
- [F1]Acquired due to the net exercise of stock options granted 2/25/21, 2/25/22, 2/24/23 and 2/23/24 with shares withheld by the Company to cover the exercise price and taxes. This transaction was completed subsequent to the execution of a Lock-Up Agreement and shares received are subject to the provisions of that agreement.
Documents
Issuer
NATIONAL HEALTH INVESTORS INC
CIK 0000877860
Related Parties
1- filerCIK 0001630773
Filing Metadata
- Form type
- 4
- Filed
- Aug 26, 8:00 PM ET
- Accepted
- Aug 27, 5:15 PM ET
- Size
- 40.5 KB